ClinicalTrials.gov
ClinicalTrials.gov Menu

EGESTA - Emergent GI Therapy for Severe, Complicated CDI Using Fecal Microbiota Transplant (EGESTA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02968511
Recruitment Status : Withdrawn (Lack of eligible patients)
First Posted : November 18, 2016
Last Update Posted : November 27, 2017
Sponsor:
Collaborator:
OpenBiome
Information provided by (Responsible Party):
David B. Stewart, MD, FACS, FASCRS, Milton S. Hershey Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : November 14, 2017
  Actual Study Completion Date : November 14, 2017